|
You et al.
|
2008
|
522
|
Quality of life (QOL) after extended (201) vs segmental (321) colon resection
|
Extended resection yielded compromised bowel function, with decreased QOL
|
|
Zhang et al.
|
2013
|
14
|
En bloc pancreaticoduodenectomy (PD) and right hemicolectomy in right colon cancer
|
Outcomes no worse than stage-matched patients without adjacent organ involvement
|
|
Temple et al.
|
2014
|
635
|
PD (607) vs PD with colon resection (28)
|
No significant difference in post-operative mortality
|
|
Cirocchi et al.
|
2014
|
53
|
En bloc (39) vs local resection (14) in locally advanced right colon cancer
|
En bloc resection improved overall 5-year survival
|
|
Kalady et al.
|
2010
|
296
|
Segmental (253) vs total colectomy (43) in HNPCC
|
Segmental resection increases the risk of metachronous colon cancer
|
|
Berg et al.
|
2013
|
204
|
Impact of tumor genetics on lymph node harvest in stage I–III colon cancer
|
Node harvest was greatest for cancers with MSI but without KRAS/BRAF
|
|
Samdani et al.
|
2015
|
256
|
Effect of mismatch repair deficiency on lymph node yield in colorectal cancer
|
Mismatch repair deficiency did not predict lymph node yield
|
|
Sugimoto et al.
|
2015
|
4172
|
Prognostic value of lymph node ratio in stage III colon cancer
|
Lymph node ratio, with a cutoff value of 0.18, was a significant independent prognostic factor
|
|
Hong et al.
|
2014
|
321
|
Comparison of adjuvant chemotherapy (fluorouracil and leucovorin (161) vs FOLFOX (160)) in stage II–III rectal cancer after neoadjuvant chemoradiotherapy and resection
|
Adjuvant FOLFOX improved survival compared to adjuvant fluorouracil and leucovorin
|
|
de Vos tot Nederveen Cappel et al.
|
2004
|
92
|
Effect of adjuvant therapy with 5-FU (28) vs no adjuvant therapy (64) in stage III colon cancer of HNPCC
|
5-year survival did not differ
|
